Skip to Content
Merck
CN

T5830

Trap-101 hydrochloride

≥98% (HPLC), powder

Synonym(s):

1-[1-(cyclooctylmethyl)-1,2,3,6-tetrahydro-5-(hydroxymethyl)-4-pyridinyl]-3-ethyl-1,3-dihydro-2Hbenzimidazol-2-one hydrochloride

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C24H35N3O2·HCl
CAS Number:
1216621-00-9
Molecular Weight:
434.01
NACRES:
NA.77
PubChem Substance ID:
329826831
UNSPSC Code:
12352200
MDL number:
MFCD09971083

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

YEVMLMQAMCKVSC-UHFFFAOYSA-N

SMILES string

Cl.CCN1C(=O)N(C2=C(CO)CN(CC2)CC3CCCCCCC3)c4ccccc14

InChI

1S/C24H35N3O2.ClH/c1-2-26-22-12-8-9-13-23(22)27(24(26)29)21-14-15-25(17-20(21)18-28)16-19-10-6-4-3-5-7-11-19;/h8-9,12-13,19,28H,2-7,10-11,14-18H2,1H3;1H

assay

≥98% (HPLC)

form

powder

color

white to off-white

solubility

H2O: ≥10 mg/mL

storage temp.

2-8°C

Biochem/physiol Actions

Trap-101 Hydrochloride is a nociceptin/orphanin FQ peptide (NOP) receptor blocker.
Trap-101 Hydrochloride is a nociceptin/orphanin FQ peptide (NOP) receptor blocker. Trap-101 acts as an inverse agonist. Trap-101 had been found to be an effective NOP receptor antagonist both in vitro and in vivo, with equivalent potency to J113397.

pictograms

Skull and crossbones
GHS06

signalword

Danger

hcodes

H301

Hazard Classifications

Acute Tox. 3 Oral

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
100M4629V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Hope S Rugo et al.
Breast cancer research and treatment, 141(3), 461-470 (2013-09-26)
Data characterizing demographics, treatment patterns, and clinical outcomes in black patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC) are limited. registHER is a large, observational cohort study of patients (n = 1,001) with HER2-positive MBC diagnosed ≤6 months
Rong Chen et al.
Cancer chemotherapy and pharmacology, 72(5), 1111-1123 (2013-09-26)
The aim of this study was to describe the nonlinear pharmacokinetics of total and unbound plasma cisplatin under different administered time in patients with non-small-cell lung carcinoma. Patients receiving chemotherapy with cisplatin were included in this analysis. Patients were divided
Katsumi Shibata et al.
Journal of nutritional science and vitaminology, 59(4), 343-346 (2013-09-26)
Most Japanese women do not consume the estimated average requirement of vitamin B6 (1.7 mg/d) during pregnancy. Nevertheless, these deficiencies are not reported. We investigated a nutritional biomarker of vitamin B6 in pregnant Japanese women as well as their vitamin
Wenhui Zhao et al.
Diabetes care, 36(11), 3591-3598 (2013-09-26)
Diabetes confers a very high risk of lower-extremity amputation (LEA); however, few studies have assessed whether blood glucose control can reduce LEA risk among patients with diabetes, especially in practice settings where low-income patients predominate. We performed a prospective cohort
Naoki Ozeki et al.
The British journal of ophthalmology, 97(12), 1538-1542 (2013-09-26)
To evaluate the association between the magnitude of relative afferent pupillary defect (RAPD) and the laterality of visual fields in glaucoma patients using pupillography. Evaluations were made with an RAPDx (Konan Medical USA, Irvine, California, USA), which is designed to
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service